lobbying_activities: 3242138

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3242138	81798433-6752-4449-ab3f-64d58a7b7a15	Q3	IPOLICY SOLUTIONS	401105127	ASSOCIATION FOR MOLECULAR PATHOLOGY	2024	third_quarter	MED	No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests"	HOUSE OF REPRESENTATIVES,SENATE	70500		0	0	2024-10-17T10:14:36-04:00